The aim of this clinical trial is to investigate the efficacy (by monitoring the wound surface area reduction of Diabetic Foot Ulcers) and safety (by monitoring adverse events) of the medicinal product to be studied after one single application on the wound surface of patients with diabetic neuropathic ulcer.